Abstract Surgical cytoreduction for patients with malignant pleural mesothelioma (MPM) is used selected as a part of multi-modality management strategy. Our group has previously described the clinical use photodynamic therapy (PDT), form non-ionizing radiation, an intraoperative option MPM. Although necessary removal bulk disease, effects surgery on residual MPM burden are not understood. In th...